---
title: "Verzenio (abemaciclib), all indications: Specific populations questions"
description: "Specific populations questions on Verzenio (abemaciclib) that apply to every indication, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Pregnancy and breastfeeding and Pediatric use. Questions: Can Verzenio be used during pregnancy? How long should birth control be used after stopping Verzenio? Can Verzenio be used while breastfeeding? Does Verzenio affect male fertility? 3 further questions follow. 7 questions quoted from 1 source."
canonical: "https://www.evicenter.com/medical-information/verzenio/specific-populations"
published: "2026-11-14T01:54:55-05:00"
modified: "2026-11-14T16:49:54-05:00"
---

# Verzenio (abemaciclib), all indications: Specific populations questions

Manufacturer: Lilly USA, LLC  
Prescribing information: [Verzenio](https://uspl.lilly.com/verzenio/verzenio.html#pi)  
Indication pages: [HR-positive HER2-negative early breast cancer](https://www.evicenter.com/medical-information/verzenio--hr-positive-her2-negative-early-breast-cancer)

## Pregnancy and breastfeeding

<a id="verzenio-pregnancy"></a>

### Can Verzenio be used during pregnancy?

> “Based on findings from animal studies and the mechanism of action, VERZENIO can cause fetal harm when administered to a pregnant woman. In animal reproduction studies, administration of abemaciclib to pregnant rats during the period of organogenesis caused teratogenicity and decreased fetal weight at maternal exposures that were similar to the human clinical exposure based on area under the curve (AUC) at the maximum recommended human dose.”

Source: [VERZENIO: Prescribing information, captured 2026-11-14](https://uspl.lilly.com/verzenio/verzenio.html#pi:~:text=Based%20on%20findings%20from%20animal,the%20maximum%20recommended%20human%20dose.)

> “Advise pregnant women of the potential risk to a fetus. Advise females of reproductive potential to use effective contraception during treatment with VERZENIO and for 3 weeks after the last dose [see Use in Specific Populations (8.1, 8.3) and Clinical Pharmacology (12.1)].”

Source: [VERZENIO: Prescribing information, captured 2026-11-14](https://uspl.lilly.com/verzenio/verzenio.html#pi:~:text=Advise%20pregnant%20women%20of%20the,8.3%29%20and%20Clinical%20Pharmacology%20%2812.1%29%5D.)

> “Refer to the Prescribing Information of the agents administered in combination with VERZENIO for pregnancy information.”

Source: [VERZENIO: Prescribing information, captured 2026-11-14](https://uspl.lilly.com/verzenio/verzenio.html#pi:~:text=Refer%20to%20the%20Prescribing%20Information%20of,with%20VERZENIO%20for%20pregnancy%20information.)

<a id="verzenio-contraception"></a>

### How long should birth control be used after stopping Verzenio?

> “Advise females of reproductive potential to use effective contraception during VERZENIO treatment and for 3 weeks after the last dose.”

Source: [VERZENIO: Prescribing information, captured 2026-11-14](https://uspl.lilly.com/verzenio/verzenio.html#pi:~:text=Females-,Advise%20females%20of%20reproductive%20potential%20to%20use%20effective%20contraception%20during,weeks%20after%20the%20last%20dose.)

> “Refer to the Prescribing Information of the agents administered in combination with VERZENIO for contraception and infertility information. When used in combination, advise patients to use effective contraception during treatment and for the longest post-treatment duration recommended in the prescribing information of the individual products.”

Source: [VERZENIO: Prescribing information, captured 2026-11-14](https://uspl.lilly.com/verzenio/verzenio.html#pi:~:text=of%20Reproductive%20Potential-,Refer%20to%20the%20Prescribing%20Information%20of%20the%20agents%20administered%20in,information%20of%20the%20individual%20products.)

<a id="verzenio-breastfeeding"></a>

### Can Verzenio be used while breastfeeding?

> “There are no data on the presence of abemaciclib in human milk, or its effects on the breastfed child or on milk production. Because of the potential for serious adverse reactions in breastfed infants from VERZENIO, advise lactating women not to breastfeed during VERZENIO treatment and for 3 weeks after the last dose.”

Source: [VERZENIO: Prescribing information, captured 2026-11-14](https://uspl.lilly.com/verzenio/verzenio.html#pi:~:text=There%20are%20no%20data%20on,weeks%20after%20the%20last%20dose.)

> “Refer to the Prescribing Information of the agents administered in combination with VERZENIO for lactation information. When used in combination, advise patients to not breastfeed during treatment and for the longest post-treatment duration recommended in the prescribing information of any of the individual products.”

Source: [VERZENIO: Prescribing information, captured 2026-11-14](https://uspl.lilly.com/verzenio/verzenio.html#pi:~:text=8.2%20Lactation-,Refer%20to%20the%20Prescribing%20Information%20of%20the%20agents%20administered%20in,any%20of%20the%20individual%20products.)

## Specific populations

<a id="verzenio-male-fertility"></a>

### Does Verzenio affect male fertility?

> “Based on findings in animals, VERZENIO may impair fertility in males of reproductive potential [see Nonclinical Toxicology (13.1)].”

Source: [VERZENIO: Prescribing information, captured 2026-11-14](https://uspl.lilly.com/verzenio/verzenio.html#pi:~:text=Based%20on%20findings%20in%20animals%2C,potential%20%5Bsee%20Nonclinical%20Toxicology%20%2813.1%29%5D.)

> “Abemaciclib may impair fertility in males of reproductive potential. In repeat-dose toxicity studies up to 3-months duration, abemaciclib-related findings in the testis, epididymis, prostate, and seminal vesicle at doses ≥10 mg/kg/day in rats and ≥0.3 mg/kg/day in dogs included decreased organ weights, intratubular cellular debris, hypospermia, tubular dilatation, atrophy, and degeneration/necrosis. These doses in rats and dogs resulted in approximately 2 and 0.02 times, respectively, the exposure (AUC) in humans at the maximum recommended human dose. In a rat male fertility study, abemaciclib had no effects on mating and fertility at oral doses up to 10 mg/kg/day (approximately 2 times the exposure at the maximum recommended human dose based on AUC).”

Source: [VERZENIO: Prescribing information, captured 2026-11-14](https://uspl.lilly.com/verzenio/verzenio.html#pi:~:text=Abemaciclib%20may%20impair%20fertility%20in,human%20dose%20based%20on%20AUC%29.)

<a id="verzenio-kidney-impairment"></a>

### Does Verzenio need a dose adjustment for kidney impairment?

> “No dosage adjustment is required for patients with mild or moderate renal impairment (CLcr ≥30-89 mL/min, estimated by Cockcroft-Gault [C-G]). The pharmacokinetics of abemaciclib in patients with severe renal impairment (CLcr <30 mL/min, C-G), end stage renal disease, or in patients on dialysis is unknown [see Clinical Pharmacology (12.3)].”

Source: [VERZENIO: Prescribing information, captured 2026-11-14](https://uspl.lilly.com/verzenio/verzenio.html#pi:~:text=No%20dosage%20adjustment%20is%20required,unknown%20%5Bsee%20Clinical%20Pharmacology%20%2812.3%29%5D.)

<a id="verzenio-liver-impairment"></a>

### Does Verzenio need a dose adjustment for liver impairment?

> “For patients with severe hepatic impairment (Child Pugh-C), reduce the VERZENIO dosage frequency to once daily [see Use in Specific Populations (8.7) and Clinical Pharmacology (12.3)].”

Source: [VERZENIO: Prescribing information, captured 2026-11-14](https://uspl.lilly.com/verzenio/verzenio.html#pi:~:text=For%20patients%20with%20severe%20hepatic%20impairment%20%28Child,%288.7%29%20and%20Clinical%20Pharmacology%20%2812.3%29%5D.)

> “No dosage adjustments are necessary in patients with mild or moderate hepatic impairment (Child-Pugh A or B).”

Source: [VERZENIO: Prescribing information, captured 2026-11-14](https://uspl.lilly.com/verzenio/verzenio.html#pi:~:text=No%20dosage%20adjustments%20are%20necessary,impairment%20%28Child%2DPugh%20A%20or%20B%29.)

> “In subjects with severe hepatic impairment, the mean plasma elimination half-life of abemaciclib increased to 55 hours compared to 24 hours in subjects with normal hepatic function.”

Source: [VERZENIO: Prescribing information, captured 2026-11-14](https://uspl.lilly.com/verzenio/verzenio.html#pi:~:text=In%20subjects%20with%20severe%20hepatic%20impairment%2C,subjects%20with%20normal%20hepatic%20function.)

## Pediatric use

<a id="verzenio-children"></a>

### Is Verzenio approved for children?

> “The safety and effectiveness of VERZENIO have not been established in pediatric patients.”

Source: [VERZENIO: Prescribing information, captured 2026-11-14](https://uspl.lilly.com/verzenio/verzenio.html#pi:~:text=The%20safety%20and%20effectiveness%20of,been%20established%20in%20pediatric%20patients.)

## Related pages
- [Medical information: Verzenio (abemaciclib): All indications](https://www.evicenter.com/medical-information/verzenio)
- [Indication](https://www.evicenter.com/medical-information/verzenio/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/verzenio/pharmacology)
- [Safety](https://www.evicenter.com/medical-information/verzenio/safety)
- [Drug interactions](https://www.evicenter.com/medical-information/verzenio/drug-interactions)
- [Dosing and administration](https://www.evicenter.com/medical-information/verzenio/dosing-and-administration)
- [Storage and supply](https://www.evicenter.com/medical-information/verzenio/storage-and-supply)
- [Access and coverage](https://www.evicenter.com/medical-information/verzenio/access-and-coverage)
